Ali Zirakzadeh et al found that an increased number of tumor-associated CD38 + cells in bladder cancer pathology may exert a positive impact on survival in urothelial bladder carcinoma patients,[57] which to some extent is consistent with our research results. This evidence concerns the gene CD38 and bladder transitional cell carcinoma.